These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2752113)

  • 1. Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma.
    Tefferi A; Owen BA; Nichols WL; Witzig TE; Owen WG
    Blood; 1989 Jul; 74(1):252-4. PubMed ID: 2752113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia.
    Bussel JB; Steinherz PG; Miller DR; Hilgartner MW
    Am J Hematol; 1984 Jan; 16(1):83-90. PubMed ID: 6582779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma.
    Horne MK; Chao ES; Wilson OJ; Scialla SJ; Lynch MA; Kragel PJ
    J Lab Clin Med; 1991 Sep; 118(3):250-60. PubMed ID: 1919298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.
    Liebman HA; Comenzo R; Allen ST; Dilorio JM
    Am J Hematol; 1991 Sep; 38(1):24-9. PubMed ID: 1897511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis.
    Delorme MA; Saeed N; Sevcik A; Mitchell L; Berry L; Johnston M; Andrew M
    Blood; 1993 Dec; 82(11):3380-5. PubMed ID: 8241508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.
    Khoory MS; Nesheim ME; Bowie EJ; Mann KG
    J Clin Invest; 1980 Mar; 65(3):666-74. PubMed ID: 6444419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma.
    Wages DS; Staprans I; Hambleton J; Bass NM; Corash L
    Am J Hematol; 1998 Aug; 58(4):285-92. PubMed ID: 9692391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of an acquired antithrombin antibody.
    Lawson JH; Pennell BJ; Olson JD; Mann KG
    Blood; 1990 Dec; 76(11):2249-57. PubMed ID: 2257299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-like anticoagulant associated with plasma cell myeloma.
    Chapman GS; George CB; Danley DL
    Am J Clin Pathol; 1985 Jun; 83(6):764-6. PubMed ID: 3923825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-bound heparin/heparan sulfates in human adult and umbilical cord plasma.
    Xiao H; Miller SJ; Bang NU; Faulk WP
    Haemostasis; 1999; 29(4):237-46. PubMed ID: 10702706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
    Teoh KH; Young E; Bradley CA; Hirsh J
    Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding proteins are involved in thrombin time variability in normal and patient plasmas.
    Xiao H; Miller S; Faulk WP
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):455-60. PubMed ID: 10937807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein.
    Kluszynski BA; Kim C; Faulk WP
    J Biol Chem; 1997 May; 272(21):13541-7. PubMed ID: 9153200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
    Shariat SF; Monoski MA; Andrews B; Wheeler TM; Lerner SP; Slawin KM
    Urology; 2003 May; 61(5):1053-8. PubMed ID: 12736046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-like anticoagulant associated with systemic candidiasis.
    Horne MK; Chao ES; Wilson OJ
    Am J Hematol; 1990 Sep; 35(1):37-42. PubMed ID: 2389767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reptilase time (RT).
    Karapetian H
    Methods Mol Biol; 2013; 992():273-7. PubMed ID: 23546720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.